ZYN002 is safe and effectively reduces irritability-related behavioral symptoms in children and adolescents with fragile X ...

Treatment with inebilizumab is significantly effective and safe for patients with AChR+ or MuSK+ generalized myasthenia ...

Patients who take foslevodopa/foscarbidopa who wake in the "ON" state show improved motor function, daily activities, and ...

The use of oral edaravone for a total of 144 weeks is safe and well-tolerated among patients with amyotrophic lateral ...

Women and racial-ethnic minorities remain underrepresented in academic neurology, especially in higher ranks and leadership ...

Neurophobia among Hispanic medical students may deter them from choosing neurology, potentially leading to a future shortage ...

Among patients with narcolepsy, AXS-12 (reboxetine) vs placebo significantly reduced the frequency of cataplexy attacks.

Increased physical activity, energy expenditure, and reduced sedentary behavior are protective in lowering the risk for neuropsychiatric diseases.

Over the last 2 decades, aspiration pneumonia and Alzheimer disease-related mortality have significantly decreased in older ...

Hypertension-related vascular dementia mortality rates have increased over the past 15 years, especially among Black and African American individuals.

Fremanezumab is safe, effective, and tolerable for children and adolescents with episodic migraine, reducing monthly migraine ...

Patients with relapsing MS treated with tolebrutinib vs teriflunomide had a clear reduction in disability accumulation with ...